Wagner disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:898OMIM:143200H35.5
Who is this for?
Show terms as
13Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Wagner disease (also called Wagner vitreoretinal degeneration or Wagner syndrome) is a rare inherited eye condition that affects the gel-like fluid inside the eye called the vitreous, as well as the retina — the light-sensitive layer at the back of the eye. In people with Wagner disease, the vitreous becomes abnormally thin and liquefied instead of staying firm and clear. Over time, this leads to serious problems with vision. The condition is caused by changes (mutations) in the VCAN gene, which provides instructions for making a protein called versican that helps maintain the structure of the eye. The main symptoms include poor night vision, reduced side (peripheral) vision, and a gradual decline in overall eyesight. Many people also develop cataracts (clouding of the eye's lens) and are at increased risk of retinal detachment, which is a medical emergency. Some people may also develop a condition where the retina slowly wastes away (chorioretinal atrophy). There is currently no cure for Wagner disease. Treatment focuses on managing complications — for example, surgery for cataracts or retinal detachment, and regular monitoring by an eye specialist. With careful follow-up and timely treatment of complications, many people can preserve useful vision for many years, though vision loss tends to worsen slowly over time.

Also known as:

Key symptoms:

Blurry or reduced visionPoor night vision (difficulty seeing in low light)Loss of side (peripheral) visionFloaters or unusual shapes seen in the field of visionCataracts (clouding of the lens inside the eye)Retinal detachment (the retina peeling away from the back of the eye)Gradual wasting away of the retina and underlying tissue (chorioretinal atrophy)Nearsightedness (myopia)Abnormally thin or liquefied vitreous gel inside the eyePossible complete vision loss in severe or untreated cases

Clinical phenotype terms (13)— hover any for plain English
Chorioretinal atrophyHP:0000533Presenile cataractsHP:0007819Abnormal full-field electroretinogramHP:0030466Optically empty vitreousHP:0030663Ectopic foveaHP:0025007Anterior uveitisHP:0012122
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

4 events
Nov 2025Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

Eluciderm Inc — PHASE1, PHASE2

TrialRECRUITING
May 2025Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

Samaritan Biologics — NA

TrialRECRUITING
Apr 2025Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

Estar Medical dba Medical Technologies, LTD — PHASE2

TrialRECRUITING
Feb 2024SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

PolarityTE — PHASE3

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Wagner disease.

View clinical trials →

No actively recruiting trials found for Wagner disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Wagner disease community →

Specialists

13 foundView all specialists →
NP
Nikolai Sopko, MD, PhD
TWIN FALLS, ID
Specialist
PI on 2 active trials
AM
Adrianne P Smith, MD
Specialist
PI on 1 active trial1 Wagner disease publication
MM
Marcus L. Gitterle, MD
NEW BRAUNFELS, TX
Specialist
PI on 1 active trial
GN
Guang Ning
Specialist
PI on 1 active trial17 Wagner disease publications
BD
BaekKyu Kim, MD. Ph D
Specialist
PI on 1 active trial
JD
JunPio Hong, MD. Ph D
Specialist
PI on 1 active trial
JD
JiUng Bak, MD. Ph D
Specialist
PI on 1 active trial
YD
YeongCheol Seo, MD. Ph D
Specialist
PI on 1 active trial
SD
SeungKyu Han, MD. Ph D
Specialist
PI on 1 active trial5 Wagner disease publications
TM
Thomas E Serena, MD
SHENANDOAH, TX
Specialist
PI on 2 active trials
RD
Robert J. Snyder, DPM
Specialist
PI on 2 active trials
DP
David Armstrong, DPM, MD, PhD
Specialist
PI on 2 active trials
AM
Anne Laumann, MBChB, MRCP
CANAAN, NH
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Wagner disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Wagner diseaseForum →

No community posts yet. Be the first to share your experience with Wagner disease.

Start the conversation →

Latest news about Wagner disease

Disease timeline:

New recruiting trial: Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

A new clinical trial is recruiting patients for Wagner disease

New recruiting trial: Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

A new clinical trial is recruiting patients for Wagner disease

New recruiting trial: Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

A new clinical trial is recruiting patients for Wagner disease

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How advanced is my Wagner disease right now, and what changes should I watch for?,How often should I have eye exams, and what specific tests do I need each time?,What are the warning signs of retinal detachment, and what should I do if I notice them?,Should my children or other family members be tested for this condition?,Are there any clinical trials or new treatments I should know about?,What low vision services or aids might help me maintain my independence?,Should I see a genetic counselor to understand the risk of passing this on to my children?

Common questions about Wagner disease

What is Wagner disease?

Wagner disease (also called Wagner vitreoretinal degeneration or Wagner syndrome) is a rare inherited eye condition that affects the gel-like fluid inside the eye called the vitreous, as well as the retina — the light-sensitive layer at the back of the eye. In people with Wagner disease, the vitreous becomes abnormally thin and liquefied instead of staying firm and clear. Over time, this leads to serious problems with vision. The condition is caused by changes (mutations) in the VCAN gene, which provides instructions for making a protein called versican that helps maintain the structure of the

How is Wagner disease inherited?

Wagner disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Wagner disease?

13 specialists and care centers treating Wagner disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.